share_log

UBS Maintains Buy on Tenet Healthcare, Raises Price Target to $217

Benzinga ·  Oct 30 10:12  · Ratings

UBS analyst A.J. Rice maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $197 to $217.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment